TY - JOUR
T1 - Post–Covid-19 Cholangiopathy—A New Indication for Liver Transplantation
T2 - A Case Report
AU - Durazo, Francisco A.
AU - Nicholas, Allyssa A.
AU - Mahaffey, Jennifer J.
AU - Sova, Shannon
AU - Evans, John J.
AU - Trivella, Juan Pablo
AU - Loy, Veronica
AU - Kim, Joohyun
AU - Zimmerman, Michael A.
AU - Hong, Johnny C.
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/5
Y1 - 2021/5
N2 - Liver injury is one of the nonpulmonary manifestations described in coronavirus disease 2019 (COVID-19). Post–COVID-19 cholangiopathy is a special entity of liver injury that has been suggested as a variant of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). In the general population, the outcome of SSC-CIP has been reported to be poor without orthotopic liver transplantation (OLT). However, the role of OLT for post–COVID-19 cholangiopathy is unknown. We present a case report of a 47-year-old man who recovered from acute respiratory distress syndrome from COVID-19 and subsequently developed end-stage liver disease from post–COVID-19 cholangiopathy. The patient underwent OLT and is doing well with normal liver tests for 7 months. To our knowledge, this is the first case report of a patient who underwent successful liver transplantation for post–COVID-19 cholangiopathy.
AB - Liver injury is one of the nonpulmonary manifestations described in coronavirus disease 2019 (COVID-19). Post–COVID-19 cholangiopathy is a special entity of liver injury that has been suggested as a variant of secondary sclerosing cholangitis in critically ill patients (SSC-CIP). In the general population, the outcome of SSC-CIP has been reported to be poor without orthotopic liver transplantation (OLT). However, the role of OLT for post–COVID-19 cholangiopathy is unknown. We present a case report of a 47-year-old man who recovered from acute respiratory distress syndrome from COVID-19 and subsequently developed end-stage liver disease from post–COVID-19 cholangiopathy. The patient underwent OLT and is doing well with normal liver tests for 7 months. To our knowledge, this is the first case report of a patient who underwent successful liver transplantation for post–COVID-19 cholangiopathy.
UR - http://www.scopus.com/inward/record.url?scp=85103958333&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103958333&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2021.03.007
DO - 10.1016/j.transproceed.2021.03.007
M3 - Article
C2 - 33846012
AN - SCOPUS:85103958333
SN - 0041-1345
VL - 53
SP - 1132
EP - 1137
JO - Transplantation proceedings
JF - Transplantation proceedings
IS - 4
ER -